John Mumm

Company: DEKA Biosciences

Job title: Chief Executive Officer & Co- Founder

Seminars:

Improving Potency & Reducing Toxicity; Combining T cell Engagers with DiakinesTM 4:00 pm

• DiakinesTM independently accumulate in the T cell synapse, enhancing T cell avidity for tumor cells • DiakinesTM independently stimulate and enhance T cell function and permit the same 100% cytotoxicity with 1 – 2 logs less T cell engager concentrations • DiakinesTM combinatorically suppress CRS stimulated by T cell engagers by controlling cytokines secreted…Read more

day: Day One